10-K Filing

BEONE MEDICINES LTD. CIK: 1651308 FY 2017

Filing Information

Form Type	10-K
Accession Number	`0001558370-18-001303`
Period End Date	20171231
Filing Date	20180228
Fiscal Year	2017
Fiscal Period	FY
XBRL Instance	bgne-20171231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 72 Income Statement 88 Cash Flow Statement 120 Stockholders Equity 33 Comprehensive Income 24

Balance Sheet 72 line items

Line Item	Tag	Value	Unit	Period
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Ordinary shares, shares authorized	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.90M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$17.87M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$87.51M	USD	Point-in-time
Ordinary shares, shares authorized	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$239.60M	USD	Point-in-time
Ordinary shares, shares issued	`CommonStockSharesIssued`	515.83M	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$280.66M	USD	Point-in-time
Ordinary shares, shares issued	`CommonStockSharesIssued`	592.07M	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$597.91M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$29.43M	USD	Point-in-time
Ordinary shares, shares outstanding	`CommonStockSharesOutstanding`	515.83M	shares	Point-in-time
Ordinary shares, shares outstanding	`CommonStockSharesOutstanding`	592.07M	shares	Point-in-time
Inventories	`InventoryNet`	$10.93M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$6.22M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$35.62M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$374.40M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$913.50M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$62.57M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$25.98M	USD	Point-in-time
Land use right, net	`LandUseRightNet`	$12.46M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$7.25M	USD	Point-in-time
Goodwill	`Goodwill`	$109.00K	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$7.67M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$768.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$4.67M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$42.91M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$132.98M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$31.41M	USD	Point-in-time
Total assets	`Assets`	$1.05B	USD	Point-in-time
Total assets	`Assets`	$405.81M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$69.78M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$11.96M	USD	Point-in-time
Accrued expenses and other payables	`AccruedLiabilitiesAccountsPayableOtherAndOtherLiabilitiesCurrent`	$49.60M	USD	Point-in-time
Accrued expenses and other payables	`AccruedLiabilitiesAccountsPayableOtherAndOtherLiabilitiesCurrent`	$22.30M	USD	Point-in-time
Deferred revenue, current portion	`DeferredRevenueCurrent`	$12.23M	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$9.16M	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$804.00K	USD	Point-in-time
Current portion of long-term bank loan	`LongTermDebtCurrent`	$9.22M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$35.06M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$149.99M	USD	Point-in-time
Long-term bank loan	`LongTermDebtNoncurrent`	$17.28M	USD	Point-in-time
Long-term bank loan	`LongTermDebtNoncurrent`	$9.22M	USD	Point-in-time
Shareholder loan	`DueToRelatedPartiesNoncurrent`	$146.27M	USD	Point-in-time
Deferred revenue, non-current portion	`DeferredRevenueNoncurrent`	$24.81M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$31.96M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$564.00K	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$212.26M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$17.85M	USD	Point-in-time
Total liabilities	`Liabilities`	$362.25M	USD	Point-in-time
Total liabilities	`Liabilities`	$52.91M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Ordinary shares (par value of US$0.0001 per share; 9,500,000,000 shares authorized; 592,072,330 shares issued and outstanding as of December 31, 2017 (December 31, 2016: 515,833,609 shares))	`CommonStockValue`	$52.00K	USD	Point-in-time
Ordinary shares (par value of US$0.0001 per share; 9,500,000,000 shares authorized; 592,072,330 shares issued and outstanding as of December 31, 2017 (December 31, 2016: 515,833,609 shares))	`CommonStockValue`	$59.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$591.21M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.00B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-480.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-946.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-330.52M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-237.41M	USD	Point-in-time
Total BeiGene, Ltd. shareholders' equity	`StockholdersEquity`	$669.81M	USD	Point-in-time
Total BeiGene, Ltd. shareholders' equity	`StockholdersEquity`	$352.91M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$14.42M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-101.77M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$352.91M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-53.04M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$684.23M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$1.05B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$405.81M	USD	Point-in-time

Income Statement 88 line items

Line Item	Tag	Value	Unit	Period
Product revenue, net	`SalesRevenueGoodsNet`	$24.43M	USD	Annual
Collaboration revenue	`CollaborationRevenue`	$8.82M	USD	Annual
Collaboration revenue	`CollaborationRevenue`	$213.96M	USD	Annual
Collaboration revenue	`CollaborationRevenue`	$1.07M	USD	Annual
Total revenues	`Revenues`	$238.39M	USD	Annual
Total revenues	`Revenues`	$677.00K	USD	1 Quarter
Total revenues	`Revenues`	$18.17M	USD	1 Quarter
Total revenues	`Revenues`	$8.82M	USD	Annual
Total revenues	`Revenues`	$1.07M	USD	Annual
Total revenues	`Revenues`	$220.21M	USD	1 Quarter
Total revenues	`Revenues`	$393.00K	USD	1 Quarter
Cost of sales - product	`CostOfGoodsSold`	$4.97M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$58.25M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$98.03M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$269.02M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$7.31M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$20.10M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$62.60M	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	-	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	-	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$250.00K	USD	Annual
Total expenses	`CostsAndExpenses`	$118.13M	USD	Annual
Total expenses	`CostsAndExpenses`	$65.56M	USD	Annual
Total expenses	`CostsAndExpenses`	$336.84M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$114.91M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-58.02M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-98.46M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-56.74M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-51.54M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-20.33M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-24.63M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-103.80M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-34.83M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-117.06M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-37.27M	USD	1 Quarter
Interest (expense) income, net	`InterestIncomeExpenseNet`	$-4.11M	USD	Annual
Interest (expense) income, net	`InterestIncomeExpenseNet`	$559.00K	USD	Annual
Interest (expense) income, net	`InterestIncomeExpenseNet`	$383.00K	USD	Annual
Changes in fair value of financial instruments	`GainsLossesFromDecreaseIncreaseInFairValueOfFinancialInstruments`	$-1.51M	USD	Annual
Changes in fair value of financial instruments	`GainsLossesFromDecreaseIncreaseInFairValueOfFinancialInstruments`	$-1.83M	USD	Annual
Gain (loss) on sale of available-for-sale securities	`AvailableForSaleSecuritiesGrossRealizedGainLossNet`	$44.00K	USD	Annual
Gain (loss) on sale of available-for-sale securities	`AvailableForSaleSecuritiesGrossRealizedGainLossNet`	$-314.00K	USD	Annual
Gain (loss) on sale of available-for-sale securities	`AvailableForSaleSecuritiesGrossRealizedGainLossNet`	$-1.42M	USD	Annual
Other income, net	`OtherNonoperatingIncomeExpense`	$1.22M	USD	Annual
Other income, net	`OtherNonoperatingIncomeExpense`	$443.00K	USD	Annual
Other income, net	`OtherNonoperatingIncomeExpense`	$11.46M	USD	Annual
Loss before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-91.06M	USD	Annual
Loss before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-57.10M	USD	Annual
Loss before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-119.16M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$54.00K	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$2.23M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	Annual
Net loss	`ProfitLoss`	$-50.62M	USD	1 Quarter
Net loss	`ProfitLoss`	$-99.28M	USD	1 Quarter
Net loss	`ProfitLoss`	$-24.12M	USD	1 Quarter
Net loss	`ProfitLoss`	$-60.68M	USD	1 Quarter
Net loss	`ProfitLoss`	$-93.30M	USD	Annual
Net loss	`ProfitLoss`	$-22.00M	USD	1 Quarter
Net loss	`ProfitLoss`	$117.28M	USD	1 Quarter
Net loss	`ProfitLoss`	$-35.49M	USD	1 Quarter
Net loss	`ProfitLoss`	$-37.60M	USD	1 Quarter
Net loss	`ProfitLoss`	$-57.10M	USD	Annual
Net loss	`ProfitLoss`	$-119.22M	USD	Annual
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-194.00K	USD	Annual
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-99.32M	USD	1 Quarter
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-57.10M	USD	Annual
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-50.62M	USD	1 Quarter
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-93.11M	USD	Annual
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-35.49M	USD	1 Quarter
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-119.22M	USD	Annual
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-24.12M	USD	1 Quarter
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-22.00M	USD	1 Quarter
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$117.39M	USD	1 Quarter
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-60.55M	USD	1 Quarter
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-37.60M	USD	1 Quarter
Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.08	USD	1 Quarter
Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.52	USD	Annual
Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.17	USD	Annual
Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.08	USD	1 Quarter
Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.06	USD	1 Quarter
Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	1 Quarter
Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.30	USD	Annual
Basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	110.60M	shares	Annual
Basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	403.62M	shares	Annual
Basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	543.19M	shares	Annual
Basic and diluted (in dollars per share)	`EarningsPerAmericanDepositoryShare`	$-2.23	USD	Annual
Basic and diluted (in dollars per share)	`EarningsPerAmericanDepositoryShare`	$-6.71	USD	Annual
Basic and diluted (in dollars per share)	`EarningsPerAmericanDepositoryShare`	$-3.84	USD	Annual

Cash Flow Statement 120 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-50.62M	USD	1 Quarter
Net loss	`ProfitLoss`	$-99.28M	USD	1 Quarter
Net loss	`ProfitLoss`	$-24.12M	USD	1 Quarter
Net loss	`ProfitLoss`	$-60.68M	USD	1 Quarter
Net loss	`ProfitLoss`	$-93.30M	USD	Annual
Net loss	`ProfitLoss`	$-22.00M	USD	1 Quarter
Net loss	`ProfitLoss`	$117.28M	USD	1 Quarter
Net loss	`ProfitLoss`	$-35.49M	USD	1 Quarter
Net loss	`ProfitLoss`	$-37.60M	USD	1 Quarter
Net loss	`ProfitLoss`	$-57.10M	USD	Annual
Net loss	`ProfitLoss`	$-119.22M	USD	Annual
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$1.91M	USD	Annual
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$4.76M	USD	Annual
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$1.54M	USD	Annual
Share-based compensation expenses	`ShareBasedCompensation`	$10.21M	USD	Annual
Share-based compensation expenses	`ShareBasedCompensation`	$10.62M	USD	Annual
Share-based compensation expenses	`ShareBasedCompensation`	$42.86M	USD	Annual
Changes in fair value of financial instruments	`GainsLossesFromDecreaseIncreaseInFairValueOfFinancialInstruments`	$-1.51M	USD	Annual
Changes in fair value of financial instruments	`GainsLossesFromDecreaseIncreaseInFairValueOfFinancialInstruments`	$-1.83M	USD	Annual
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-5.00K	USD	Annual
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-85.00K	USD	Annual
Non-cash interest expense	`InterestExpenseOperatingActivities`	$1.09M	USD	Annual
Non-cash interest expense	`InterestExpenseOperatingActivities`	$121.00K	USD	Annual
Non-cash interest expense	`InterestExpenseOperatingActivities`	$7.04M	USD	Annual
Deferred income tax benefits	`DeferredIncomeTaxesAndTaxCredits`	$-5.84M	USD	Annual
Deferred income tax benefits	`DeferredIncomeTaxesAndTaxCredits`	$-768.00K	USD	Annual
Other non-cash expenses	`OtherNoncashIncomeExpense`	$-314.00K	USD	Annual
Other non-cash expenses	`OtherNoncashIncomeExpense`	$44.00K	USD	Annual
Other non-cash expenses	`OtherNoncashIncomeExpense`	$-1.42M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$29.43M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$10.93M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.07M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.99M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$28.88M	USD	Annual
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$565.00K	USD	Annual
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-112.00K	USD	Annual
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$29.70M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$55.30M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$6.19M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.71M	USD	Annual
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$13.95M	USD	Annual
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$7.35M	USD	Annual
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$24.98M	USD	Annual
Tax payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$7.43M	USD	Annual
Tax payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$804.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-1.07M	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$37.04M	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-7.84M	USD	Annual
Deferred rental	`IncreaseDecreaseInDeferredRentalLiabilityNoncurrent`	$182.00K	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-64.00K	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$31.39M	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$459.00K	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-89.51M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-39.84M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$12.75M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$5.31M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$46.37M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$23.50M	USD	Annual
Payment for the acquisition of land use right	`PaymentsToLandUseRights`	$12.35M	USD	Annual
Cash acquired in business combination, net of cash paid	`CashAcquiredFromAcquisitionNetOfCashPaid`	$19.92M	USD	Annual
Purchases of investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$119.29M	USD	Annual
Purchases of investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$382.09M	USD	Annual
Purchases of investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$741.30M	USD	Annual
Proceeds from sale or maturity of available-for-sale securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$183.74M	USD	Annual
Proceeds from sale or maturity of available-for-sale securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$423.79M	USD	Annual
Proceeds from sale or maturity of available-for-sale securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$65.70M	USD	Annual
Proceeds from disposal of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$1.00K	USD	Annual
Proceeds from disposal of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$4.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-221.85M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-58.91M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-356.32M	USD	Annual
Proceeds from public offering, net of underwriter discount	`ProceedsFromIssuancePublicOffering`	$189.19M	USD	Annual
Proceeds from public offering, net of underwriter discount	`ProceedsFromIssuancePublicOffering`	$368.88M	USD	Annual
Payment of public offering cost	`PaymentsOfStockIssuanceCosts`	$2.22M	USD	Annual
Payment of public offering cost	`PaymentsOfStockIssuanceCosts`	$674.00K	USD	Annual
Proceeds from sale of ordinary shares, net of cost	`ProceedsFromIssuanceOfCommonStockNetOfStockIssuanceCosts`	$149.93M	USD	Annual
Proceeds from issuance of convertible preferred shares	`ProceedsFromIssuanceOfConvertiblePreferredStock`	$97.35M	USD	Annual
Proceeds from long-term loan	`ProceedsFromLongTermLinesOfCredit`	$12.05M	USD	Annual
Proceeds from long-term loan	`ProceedsFromLongTermLinesOfCredit`	$6.17M	USD	Annual
Proceeds from short-term loan	`ProceedsFromShortTermDebt`	$2.47M	USD	Annual
Repayment of short-term loan	`RepaymentsOfShortTermDebt`	$2.47M	USD	Annual
Repayment of short-term loan	`RepaymentsOfShortTermDebt`	$322.00K	USD	Annual
Capital contribution from noncontrolling interest	`ProceedsFromMinorityShareholders`	$14.53M	USD	Annual
Proceeds from shareholder loan	`ProceedsFromRelatedPartyDebt`	$132.76M	USD	Annual
Proceeds from exercise of warrants and rental deferral option	`ProceedsFromWarrantExercises`	$2.12M	USD	Annual
Proceeds from option exercises	`ProceedsFromStockOptionsExercised`	$77.00K	USD	Annual
Proceeds from option exercises	`ProceedsFromStockOptionsExercised`	$4.63M	USD	Annual
Proceeds from option exercises	`ProceedsFromStockOptionsExercised`	$80.00K	USD	Annual
Payment of convertible preferred shares issuance cost	`PaymentsOfTemporaryEquityIssuanceCosts`	$75.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$490.36M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$380.90M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$103.20M	USD	Annual
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$-485.00K	USD	Annual
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$104.00K	USD	Annual
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$5.30M	USD	Annual
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$69.64M	USD	Annual
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$3.97M	USD	Annual
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$152.09M	USD	Annual
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$13.90M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$17.87M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$87.51M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$239.60M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$13.90M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$17.87M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$87.51M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$239.60M	USD	Point-in-time
Income taxes paid	`IncomeTaxesPaidNet`	$25.00K	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	$29.29M	USD	Annual
Interest expense paid	`InterestPaidNet`	$134.00K	USD	Annual
Interest expense paid	`InterestPaidNet`	$1.26M	USD	Annual
Interest expense paid	`InterestPaidNet`	$826.00K	USD	Annual
Discount provided on sale of ordinary shares for business combination	`DiscountProvidedForIssuanceOfOrdinaryShares`	$23.61M	USD	Annual
Conversion of Senior Promissory Note	`DebtConversionConvertedInstrumentAmount1`	$14.69M	USD	Annual
Conversion of deferred rental	`ConversionOfDeferredRental`	$980.00K	USD	Annual
Conversion of convertible preferred shares	`ConversionOfStockAmountIssued1`	$176.08M	USD	Annual
Exercise of warrants and option	`ConversionOfWarrantAndOptionLiabilities`	$3.69M	USD	Annual
Follow-on public offering costs accrued in accounts payable	`FollowOnOfferingCostsAccruedInAccountsPayable`	$269.00K	USD	Annual
Acquisitions of equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$23.00K	USD	Annual
Acquisitions of equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$2.21M	USD	Annual
Acquisitions of equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$2.15M	USD	Annual

Stockholders Equity 33 line items

Line Item	Tag	Value	Unit	Period
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-101.77M	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$352.91M	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-53.04M	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$684.23M	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	515.83M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	592.07M	shares	Point-in-time
Issuance of ordinary shares	`StockIssuedDuringPeriodValueNewIssues`	$76.00K	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$10.21M	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$42.86M	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$10.70M	USD	Annual
Net loss	`ProfitLoss`	$-50.62M	USD	1 Quarter
Net loss	`ProfitLoss`	$-99.28M	USD	1 Quarter
Net loss	`ProfitLoss`	$-24.12M	USD	1 Quarter
Net loss	`ProfitLoss`	$-60.68M	USD	1 Quarter
Net loss	`ProfitLoss`	$-93.30M	USD	Annual
Net loss	`ProfitLoss`	$-22.00M	USD	1 Quarter
Net loss	`ProfitLoss`	$117.28M	USD	1 Quarter
Net loss	`ProfitLoss`	$-35.49M	USD	1 Quarter
Net loss	`ProfitLoss`	$-37.60M	USD	1 Quarter
Net loss	`ProfitLoss`	$-57.10M	USD	Annual
Net loss	`ProfitLoss`	$-119.22M	USD	Annual
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$4.63M	USD	Annual
Contributions from shareholders (Note 8)	`NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest`	$14.53M	USD	Annual
Discount on the sale of ordinary shares	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$23.61M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$555.00K	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$863.00K	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-1.91M	USD	Annual
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-101.77M	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$352.91M	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-53.04M	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$684.23M	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	515.83M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	592.07M	shares	Point-in-time

Comprehensive Income 24 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-50.62M	USD	1 Quarter
Net loss	`ProfitLoss`	$-99.28M	USD	1 Quarter
Net loss	`ProfitLoss`	$-24.12M	USD	1 Quarter
Net loss	`ProfitLoss`	$-60.68M	USD	1 Quarter
Net loss	`ProfitLoss`	$-93.30M	USD	Annual
Net loss	`ProfitLoss`	$-22.00M	USD	1 Quarter
Net loss	`ProfitLoss`	$117.28M	USD	1 Quarter
Net loss	`ProfitLoss`	$-35.49M	USD	1 Quarter
Net loss	`ProfitLoss`	$-37.60M	USD	1 Quarter
Net loss	`ProfitLoss`	$-57.10M	USD	Annual
Net loss	`ProfitLoss`	$-119.22M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$851.00K	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-245.00K	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-749.00K	USD	Annual
Unrealized holding (loss) gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-296.00K	USD	Annual
Unrealized holding (loss) gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.11M	USD	Annual
Unrealized holding (loss) gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.16M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-59.01M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-118.35M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-92.74M	USD	Annual
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-105.00K	USD	Annual
Comprehensive loss attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-92.64M	USD	Annual
Comprehensive loss attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-118.35M	USD	Annual
Comprehensive loss attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-59.01M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.